Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2026-02-03 @ 10:19 AM
Study NCT ID:
NCT03833050
Status:
COMPLETED
Last Update Posted:
2022-06-14
First Post:
2019-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The TOGETHER Project - Heart
Sponsor:
Mayo Clinic
Organization:
Study Overview
Official Title:
The TOGETHER Project - Transplant Organ Genomics to Help Prevent Rejection in Heart Transplant Recipients
Status:
COMPLETED
Status Verified Date:
2022-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TOGETHER
Brief Summary:
The researchers are trying to develop a way to measure the risk of transplant rejection with a blood test.
Detailed Description:
The study will utilize peripheral blood assays collected at time points that are considered standard of care at most institutions. Subjects will have peripheral blood collected at 1 month, 3 months, 6 months, and 12 months after heart transplantation, as well as any for cause time points. These samples will then be used for purposes of developing an RNA-seq based peripheral blood assay in adult heart transplant recipients.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: